Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA’s DTC Assessment Takes Two Tracks: Internal Report And Outside Panel

Executive Summary

The Pharmaceutical Research & Manufacturers of America will issue a report in January 2007 on the implementation of its direct-to-consumer advertising "guiding principles" which will be be released in tandem with an evaluation by an independent panel

You may also be interested in...



DTC Guideline Implementation: Does “Ask Your Doctor” Spark A Dialogue?

As industry continues to implement PhRMA's guidelines on direct-to-consumer ads, debate has arisen as to how companies can effectively enact the principle that advertising should encourage a conversation between patient and physician

DTC Guideline Implementation: Does “Ask Your Doctor” Spark A Dialogue?

As industry continues to implement PhRMA's guidelines on direct-to-consumer ads, debate has arisen as to how companies can effectively enact the principle that advertising should encourage a conversation between patient and physician

PhRMA DTC Principles Compliance To Get Independent Panel Review In 2007

PhRMA is giving itself one year to monitor member companies' implementation of its new direct-to-consumer "guiding principles" before an independent panel will begin analyzing compliance and progress

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047162

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel